Analyzing databases for paracrine signaling through receptor-ligand pairs, occurring both on luminal and myoepithelial cells, we found that breast cancers with low expression of the crosstalk molecules SHH and SLIT2 resulted in significantly shorter relapse-free survivals (Supplemental Figure S5). The gene discussed is SLIT2; the disease is breast carcinoma.